Application Nr Approved Date Route Status External Links
NDA050218 None Topical None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage For The Treatment Of Corticosteroid-Responsive Dermatoses With Secondary Infection. It Has Not Been Demonstrated That This Steroid-Antibiotic Combination Provides Greater Benefit Than The Steroid Component Alone After 7 Days Of Treatment (See Warnings ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 3 Total)

Comments